NCT07021898
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07021898
Title A Study of ERAS-4001 in Patients With Advanced or Metastatic Solid Tumors. (BOREALIS-1)
Acronym BOREALIS-1
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Erasca, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Sarah Cannon Research Institute (SCRI) Oncology Partners RECRUITING Nashville Tennessee 32703 United States Details
The University of Texas MD Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
NEXT Oncology RECRUITING Irving Texas 75039 United States Details
NEXT Oncology RECRUITING San Antonio Texas 78229 United States Details
Fred Hutchinson Cancer Center RECRUITING Seattle Washington 98109 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field